Accueil › Insuffisance cardiaque › Ohio › Cincinnati
Essais cliniques pour Insuffisance cardiaque à Cincinnati, OH
24 études pour Insuffisance cardiaque recherchent des participants dans et autour de Cincinnati (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Recrutement en coursPhase 3
- Research Site, Cincinnati
- Research Site, Cincinnati
BiVACOR® Total Artificial Heart Early Feasibility Study
Recrutement en cours
- The Christ Hospital, Cincinnati
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Recrutement en coursPhase 3
- The Lindner Research Center at the Christ Hospital, Cincinnati
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Recrutement en cours
- The Christ Hospital, Cincinnati
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Recrutement en coursPhase 3
- Research Site, Cincinnati
- Research Site, Cincinnati
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Recrutement en coursPhase 3
- Cincinnati, OH Investigative Site 10088, Cincinnati
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Recrutement en cours
- The Christ Hospital - Cincinnati, Cincinnati
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Recrutement en coursPhase 2
- Local Institution - 129, Cincinnati
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Recrutement en coursPhase 2/3
- Cincinnati Children's Hospital Medical Center ( Site 0034), Cincinnati
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Recrutement en coursPhase 2
- The Lindner Center for Research & Education at The Christ Hospital, Cincinnati
NORM-HF Pivotal Study
Recrutement en cours
- Christ Hospital Lindner, Cincinnati
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Cincinnati Childrens Hospital Medical Center, Cincinnati
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Recrutement en coursÉtude observationnelle
- Cincinnati, Cincinnati
- Edgewood, Edgewood · à 8 mi
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Recrutement en coursÉtude observationnelle
- Christ Hospital Health Network, Cincinnati
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Recrutement en coursPhase 3
- Lindner Center,Christ Hospital, Cincinnati
Alleviant ALLAY-HF Study
Recrutement en cours
- St. Elizabeth Healthcare, Edgewood · à 8 mi
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Recrutement en coursPhase 3
- FIN- 10112, Cincinnati, OH, Cincinnati
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Recrutement en coursPhase 3
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Recrutement en cours
- The Christ Hospital- Cincinnati, Cincinnati
- University of Cincinnati, Cincinnati
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Recrutement en coursPhase 3
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recrutement en cours
- Christ Hospital, Cincinnati
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recrutement en cours
- Lindner Research Center at the Christ Hospital, Cincinnati
Left vs Left Randomized Clinical Trial
Recrutement en cours
- The Christ Hospital, Cincinnati
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Recrutement en coursÉtude observationnelle
- The Lindner Research Center at The Christ Hospital, Cincinnati
- St. Elizabeth Healthcare, Edgewood · à 8 mi
Essais pour Insuffisance cardiaque dans d'autres villes
- New York City, NY51 études
- Boston, MA44 études
- Dallas, TX42 études
- Houston, TX36 études
- Cleveland, OH33 études
- Chicago, IL31 études
- Philadelphia, PA31 études
- San Francisco, CA29 études
- St. Louis, MO26 études
- Durham, NC26 études
- Kansas City, MO25 études
- Atlanta, GA25 études
Autres études à Cincinnati
- Cancer du poumon non à petites cellules35 études
- Cancer (tous types)27 études
- Cancer du sein25 études
- Cancer colorectal21 études
- Leucémie aiguë myéloïde20 études
- Cancer métastatique20 études
- Cancer de l'ovaire19 études
- Cancer du poumon19 études
- Obésité19 études
- Cancer de la prostate18 études
- Myélome multiple17 études
- Mélanome17 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.